Kantoff-Sang Lecture Series – Regulatory Science: Perspectives – May 2, 2013
Regulatory science, as defined by the Food and Drug Administration (FDA) in a recent 2010 publication from the Institute of Medicine (IOM) entitled Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development, is the “science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.”
This symposium will include seven presentations by the leaders in the field:
Following presentations, the audience will be invited to explore these topics further during an hour-long panel moderated by Joshua Boger, PhD. Reception to follow.
When: May 2, 2013, 4:00-7:00pm
Where: Harvard Medical School
Members of the academic and pharmaceutical industries are welcome to attend.